PMC:3724992 / 1233-1638 JSONTXT

{"project":"2_test","denotations":[{"id":"23754640-19336457-63236733","span":{"begin":114,"end":115},"obj":"19336457"},{"id":"23754640-18182667-63236733","span":{"begin":114,"end":115},"obj":"18182667"},{"id":"23754640-18093251-63236733","span":{"begin":114,"end":115},"obj":"18093251"},{"id":"23754640-19215696-63236734","span":{"begin":293,"end":294},"obj":"19215696"},{"id":"23754640-18953491-63236734","span":{"begin":293,"end":294},"obj":"18953491"},{"id":"23754640-19766005-63236734","span":{"begin":293,"end":294},"obj":"19766005"},{"id":"23754640-19895242-63236735","span":{"begin":400,"end":401},"obj":"19895242"},{"id":"23754640-18483377-63236735","span":{"begin":400,"end":401},"obj":"18483377"},{"id":"23754640-18259692-63236735","span":{"begin":400,"end":401},"obj":"18259692"}],"text":"Astrocytoma is a common malignant primary brain tumor with a poor clinical prognosis in both adults and children [1–3]. The therapeutic options for the treatment of patients with astrocytoma are limited to three fundamental modalities: surgical resection, chemotherapy, and radiation therapy [4–6]. Cellular adoptive immunotherapy with specific CTLs has been recently used to treat malignant tumors [7–9]."}